Uniting 163 partners across 31 countries to ensure 90% of eligible patients have access to high-quality cancer care by 2028.
Envision a Europe in which every cancer patient, regardless of their location, benefits from equitable access to state-of-the-art medical care and the most advanced therapeutic innovations. This vision lies at the heart of the Joint Action European Network of Comprehensive Cancer Centres (EUnetCCC), a groundbreaking initiative launched in October 2024 under Flagship 5 of Europe’s Beating Cancer Plan and co-funded by the EU4Health programme.
Joint Action EUnetCCC is committed to realising this vision by building on the foundation established by the Joint Action CraNE (October 2022–September 2024). The initiative has an ambitious target to reach at least 100 Comprehensive Cancer Centres (CCCs) by 2028 and to create a cohesive, integrated network of centres that are either certified as CCCs or are in the process of preparing for certification. Through these efforts, the initiative will contribute greatly to ensure that 90% of eligible patients across Europe have access to high-quality, evidence-based care throughout the entire cancer continuum, regardless of their geographical location.
Bringing together 163 partner institutions from 31 countries, Joint Action EUnetCCC aims to advance cancer care through an inclusive certification framework, sustainable cross-centre partnerships emerging through a membership organisation, the seamless integration of cutting-edge research with clinical practice, and orchestrating network-based collaboration between CCCs to enhance advancement of care and research.
To achieve this, Joint Action EUnetCCC is structured into 9 dedicated work packages each focusing on a key aspect of building a strong, collaborative European cancer network to drive the mission of the Joint Action forward. With this bold commitment, Joint Action EUnetCCC is set to transform the landscape of comprehensive cancer care and establish new benchmarks for excellence, equity, and innovation throughout Europe.
Empowering equitable access to world-class cancer care by establishing a dynamic, pan-European certification ecosystem
Building sustainable expertise and infrastructure to elevate cancer care and research in every region
Fostering a vibrant, interconnected community to accelerate progress and continuous improvement for all members
Stay updated with the latest developments, announcements, and upcoming events from the EUnetCCC network.
The EUnetCCC Precision Cancer Diagnostic and the Secondary Use of Clinical Data Working Groups invite you to a webinar exploring data collection as part of Molecular tumour board operations.
Learn moreDe-escalation trials are important because they aim to reduce the intensity of medical treatments, improving patients’ quality of life and well-being by minimising toxicity and side effects—without compromising the effectiveness of cancer treatment.
Learn moreEunetCCC annual meeting is taking place as an in-person event on 6-7 November 2025 at the CNIT Forest, Paris-La Défense, Paris, France
Learn moreEUnetCCC educational seminar, "Advancing Precision Oncology Through Molecular Tumour Boards" is taking place as a hybrid event on 1–2 December 2025 at Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Learn moreOnline
Join us for the second EUnetCCC Precision Cancer Diagnostics Webinar Series to engage in conversations on improving data collection from molecular tumour board operations.
Register herePhysical
WP6 / WP9 Alignment Workshop will bring together representatives from the leaders of Work Package 6 and Work Package 9 to align activities, share tools, and synergize approaches on capacity building.
Read morePhysical
WP5 / WP9 Alignment Workshop will bring together representatives from the leaders of Work Package 5 and Work Package 9 to align approaches and identify synergies. The focus will be on defining and harmonising the interfaces between CCCs and CCCNs to ensure consistency in certification standards and collaborative processes.
Read moreHybrid, on-site preferred
The 2nd WP9 Meeting will present and discuss the progress of tasks of WP9.
Read moreParis, France
Join us for our annual conference bringing together partners and stakeholders to share progress and plan future initiatives.
Register hereBarcelona, Spain
Join us for an event with blend of expert lectures, interactive sessions and panel discussions, participants to gain practical insights into the functioning of molecular tumour boards and the latest advancements in their implementation and clinical impact.
Register hereDiscover how our nine specialised work packages in EUnetCCC are shaping the future of collaborative cancer care, research, and innovation across Europe.
